Current evidence also indicates that inhibiting NRP1 activity through any of the different possible approaches, from small molecule-mediated inhibition to RNA interference knockdown, can display antitumor effects in several cancer types and across a range of experimental models and conditions. Here, NRP1 is linked to cancer.